Sihuan Pharma (460 HK) Denies China Resources Approach
The chairman has recently been selling. He may be interested in selling more. Sihuan Parma is not expensive. I'd be picking up shares here on any weakness.
Event-Driven
396 Views, 13 May 2022 13:17
SUMMARY(Sign Up to Access)
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network